NeuroXess Secures RMB 700 Million Series B Funding for Brain-Computer Interface (BCI) Technology

Chinese BCI startup NeuroXess has closed a RMB 700 million (approximately $98 million USD) Series B funding round. The capital will accelerate the commercialization of its neural interface technology, funding multicenter clinical trials, regulatory submissions, expanded manufacturing, and next-generation product development, positioning the company to compete in the growing medical BCI market.